Table 2. HDT regulation of AR expression and response to antiandrogen post-HDT.

Patient	AR Alteration	ctDNA%/PCN Pre-HDT	HDT Responder	ctDNA%/PCN Post-HDT	Abi or Enza Post-HDT	PSA50 Responder
1	Amplification	3.9	N	ND	Enza	Y
2	AR (W742C)	1.30%	PSA50	ND	Abi	N/A
3	Amplification	1.6	PSA30	ND	Abi	N
4	Amplification	1.5	PSA50	ND	Abi	N/A
5	AR (L702H)	34.90%	N	6.80%	Enza	N
	AR (V716M)	1.20%		ND
6	Amplification	36.2	N	8.7	Enza	N/A
7	Amplification	1.4	N	ND	Enza	Y
	AR (W742L)	ND		1.20%
8	AR (T878A)	0.80%	PSA30	ND	Enza	N/A
9	AR (W742C)	0.50%	PSA30	ND	Enza	N/A
	AR (M896V)	5.30%		ND